Orion OYJ (ORINY) Stock Price, News & Analysis

Company Overview

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France. The company’s R&D organization focuses on novel chemical entities and life-cycle management of existing products, supported by a network of research partnerships and licensing agreements. In addition to human healthcare, Orion Diagnostica develops and distributes immunoassays and point-of-care tests for clinical and veterinary diagnostics.

Orion serves markets across Europe, the Nordic countries and selected regions in Asia and Latin America, leveraging both direct sales operations and partner networks. The company maintains strategic alliances to expand its geographic reach and enhance market access for its specialty products. Orion’s customer base includes hospitals, pharmacies and healthcare professionals, reflecting its long-established presence in the pharmaceutical industry.

Key Stats

• Today's Range: $38.86 to $38.86
• 50-Day Range: $37.99 to $39.00
• 52-Week Range: $30.89 to $42.75
• Volume: 132 shs
• Average Volume: 518 shs
• Market Capitalization: $10.97 billion
• P/E Ratio: 17.82
• Dividend Yield: 0.98%
• Price Target: N/A
• Consensus Rating: Hold

Orion OYJ Stock Analysis - MarketRank™

Orion OYJ scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Orion OYJ has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Orion OYJ has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Orion OYJ is 17.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 46.07.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orion OYJ is 17.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.36.

Price to Book Value per Share Ratio

Orion OYJ has a P/B Ratio of 7.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Orion OYJ has been sold short.

Short Interest Ratio / Days to Cover

Orion OYJ has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orion OYJ has recently increased by 465.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Orion OYJ has a dividend yield of 0.97%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Orion OYJ does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Orion OYJ is 17.43%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: -1.00

News Sentiment

Orion OYJ has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Orion OYJ this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Orion OYJ insiders have not sold or bought any company stock.

Percentage Held by Institutions

Orion OYJ has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 4/23/2026
• Today: 7/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ORINY
• Previous Symbol: NASDAQ:ORINY
• CIK: N/A
• Web: www.orion.fi
• Phone: 358 10 4261
• Fax: N/A
• Employees: 4,029
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $2.18
• Trailing P/E Ratio: 17.82
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $566.04 million
• Net Margins: 27.14%
• Pretax Margin: 33.64%
• Return on Equity: 49.17%
• Return on Assets: 28.54%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 1.77
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $2.14 billion
• Price / Sales: 5.13
• Cash Flow: $2.23 per share
• Price / Cash Flow: 17.41
• Book Value: $5.15 per share
• Price / Book: 7.55

Miscellaneous

• Outstanding Shares: 282,270,000
• Free Float: N/A
• Market Cap: $10.97 billion
• Optionable: Not Optionable
• Beta: 0.08